Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aprea Therapeutics Inc | 1.28m | -12.93m | 15.86m | 7.00 | -- | 0.6204 | -- | 12.43 | -3.03 | -3.03 | 0.2898 | 4.95 | 0.0435 | -- | -- | 182,241.40 | -44.09 | -68.66 | -50.11 | -77.19 | -- | -- | -1,013.41 | -42,112.84 | -- | -- | 0.00 | -- | -- | -- | 87.32 | -- | 90.61 | -- |
GlucoTrack Inc | 0.00 | -12.05m | 16.00m | 6.00 | -- | -- | -- | -- | -2.42 | -2.42 | 0.00 | -0.6004 | 0.00 | -- | -- | 0.00 | -251.32 | -94.01 | -493.89 | -142.35 | -- | -- | -- | -10,447.96 | -- | -- | -- | -- | -- | -- | -60.02 | -- | -- | -- |
Ibio Inc | 50.00k | -17.13m | 16.39m | 26.00 | -- | 0.6509 | -- | 327.70 | -13.10 | -17.09 | 0.0262 | 2.92 | 0.0011 | -- | 0.0065 | 1,923.08 | -36.24 | -28.09 | -67.39 | -32.63 | -- | -- | -34,258.00 | -1,467.30 | -- | -- | 0.3666 | -- | -100.00 | -- | 0.9764 | -- | 42.90 | -- |
AIM ImmunoTech Inc | 201.00k | -28.05m | 16.63m | 26.00 | -- | 2.72 | -- | 82.72 | -0.5703 | -0.5703 | 0.004 | 0.1068 | 0.0082 | -- | 12.18 | 7,730.77 | -113.70 | -45.64 | -149.16 | -48.35 | 71.14 | -231.75 | -13,952.74 | -11,695.01 | -- | -- | 0.3018 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
Cell Source Inc | 0.00 | -6.45m | 16.78m | -- | -- | -- | -- | -- | -0.1627 | -0.1627 | 0.00 | -0.413 | 0.00 | -- | -- | -- | -1,300.91 | -1,758.85 | -- | -- | -- | -- | -- | -- | -- | -5.14 | -- | -- | -- | -- | -3.55 | -- | -- | -- |
OpGen Inc | 1.96m | -22.39m | 16.88m | 100.00 | -- | -- | -- | 8.59 | -20.01 | -20.01 | 1.66 | -8.65 | 0.1553 | -- | 6.09 | -- | -176.99 | -87.95 | -15,455.17 | -127.65 | 3.15 | 15.42 | -1,139.66 | -794.78 | -- | -20.25 | -- | -- | 31.11 | 3.02 | 12.38 | -- | 40.20 | -- |
Synlogic Inc | 3.17m | -56.16m | 17.08m | 6.00 | -- | 1.07 | -- | 5.39 | -7.24 | -7.24 | 0.3549 | 1.37 | 0.0628 | -- | -- | 528,333.30 | -111.31 | -40.57 | -131.17 | -43.82 | -- | -- | -1,771.74 | -3,245.93 | -- | -- | 0.00 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
Mira Pharmaceuticals Inc | 0.00 | -12.78m | 17.15m | 3.00 | -- | 7.73 | -- | -- | -0.8562 | -0.8562 | 0.00 | 0.1501 | 0.00 | -- | -- | 0.00 | -373.77 | -- | -737.47 | -- | -- | -- | -- | -- | -- | -3.17 | 0.00 | -- | -- | -- | -69.77 | -- | -- | -- |
Galecto Inc | 0.00 | -25.43m | 17.23m | 13.00 | -- | 0.6347 | -- | -- | -23.45 | -23.45 | 0.00 | 21.74 | 0.00 | -- | -- | 0.00 | -59.06 | -48.46 | -75.34 | -52.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.77 | -- | -- | -- |
BioVie Inc | 0.00 | -37.18m | 17.31m | 18.00 | -- | 0.9117 | -- | -- | -9.63 | -9.63 | 0.00 | 3.10 | 0.00 | -- | -- | 0.00 | -94.32 | -456.35 | -149.75 | -1,810.88 | -- | -- | -- | -- | -- | -- | 0.2969 | -- | -- | -- | -92.67 | -- | -- | -- |
Evaxion Biotech A/S - ADR | 278.00k | -15.21m | 17.56m | 49.00 | -- | 13.60 | -- | 63.18 | -36.98 | -36.98 | 0.1048 | 0.2316 | 0.0174 | -- | 0.3493 | 5,673.47 | -95.08 | -100.11 | -126.11 | -131.65 | -- | -- | -5,469.42 | -131,560.30 | -- | -- | 0.8933 | -- | -- | -- | 4.51 | -- | 65.53 | -- |
NRX Pharmaceuticals Inc | 0.00 | -24.83m | 17.63m | 2.00 | -- | -- | -- | -- | -1.62 | -1.62 | 0.00 | -1.70 | 0.00 | -- | -- | -- | -197.97 | -120.57 | -- | -168.40 | -- | -- | -- | -- | -- | -189.12 | -- | -- | -- | -- | 24.14 | -- | -- | -- |
Bioxytran Inc | 0.00 | -3.51m | 17.74m | 2.00 | -- | -- | -- | -- | -0.023 | -0.023 | 0.00 | -0.0023 | 0.00 | -- | -- | -- | -2,635.88 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -20.68 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
Athira Pharma Inc | 0.00 | -113.45m | 17.87m | 65.00 | -- | 0.2144 | -- | -- | -2.97 | -2.97 | 0.00 | 2.17 | 0.00 | -- | -- | 0.00 | -71.06 | -30.73 | -83.81 | -32.46 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.04 | -- | -- | -- |
Cocrystal Pharma Inc | 0.00 | -17.93m | 17.91m | 12.00 | -- | 1.03 | -- | -- | -1.76 | -1.76 | 0.00 | 1.71 | 0.00 | -- | -- | 0.00 | -61.98 | -50.94 | -66.88 | -52.77 | -- | -- | -- | -1,501.78 | -- | -- | 0.00 | -- | -- | -- | 53.69 | -- | 33.34 | -- |
Data as of Sep 19 2024. Currency figures normalised to OpGen Inc's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Geode Capital Management LLCas of 31 Jul 2024 | 7.69k | 0.09% |
The Vanguard Group, Inc.as of 31 Jul 2024 | 5.33k | 0.06% |
Tower Research Capital LLCas of 30 Jun 2024 | 1.82k | 0.02% |
UBS Securities LLCas of 30 Jun 2024 | 1.25k | 0.02% |
Qube Research & Technologies Ltd.as of 30 Jun 2024 | 80.00 | 0.00% |
Bank of America, NA (Private Banking)as of 30 Jun 2024 | 8.00 | 0.00% |
RBC Dominion Securities, Inc. (Investment Management)as of 30 Jun 2024 | 5.00 | 0.00% |
NewEdge Advisors LLCas of 30 Jun 2024 | 5.00 | 0.00% |
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Jun 2024 | 1.00 | 0.00% |
SVB Wealth LLCas of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.